ClassID:

112007

C12N2795/10171 - CPC Classification

Classification description:

Bacteriophages; Details dsDNA Bacteriophages; Myoviridae Demonstrated effect

Recent Application in this class:
#1
20250281555
2025-09-11

BACTERIOPHAGE COMPOSITIONS AND METHODS FOR TREATMENT OF BACTERIAL INFECTIONS

#2
20240366694
2024-11-07

PHAGE THERAPY OF E COLI INFECTIONS

#3
20240342230
2024-10-17

BACTERIOPHAGE THERAPY

#4
20240335489
2024-10-10

Bacteriophage compositions and methods for treatment of bacterial infections

#5
20240226205
2024-07-11

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION

#6
20240209326
2024-06-27

BACTERIAL DELIVERY VEHICLE, PROCESS OF PRODUCTION AND USES THEREOF

#7
20240180980
2024-06-06

Bacteriophage compositions and methods for treatment of bacterial infections

#8
20240024391
2024-01-25

Antibacterial composition and uses thereof

#9
20230174954
2023-06-08

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION

#10
20210386805
2021-12-16

Bacteriophage therapy

#11
20210380953
2021-12-09

Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof

#12
20210330722
2021-10-28

BACTERIOPHAGE COMPOSITIONS FOR TREATING PSEUDOMONAS INFECTION

#13
20210060100
2021-03-04

Phage therapy of infections

#14
20200030392
2020-01-30

Anti-bacterial compositions and uses thereof

#15
20190390175
2019-12-26

Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof

#16
20190328803
2019-10-31

bacteriophage Vib-PAP-4 and use thereof in inhibiting proliferation of bacteria

#17
20190002840
2019-01-03

Phage therapy of infections

#18
20170333498
2017-11-23

Enterohemorrhagic bacteriophage Esc-CHP-1 and use thereof for inhibiting proliferation of enterohemorrhagic

#19
20170281700
2017-10-05

PHAGE THERAPY FOR TARGETING ENTEROCOCCI

#20
20170000831
2017-01-05

Phage therapy of infections

#21
20160264941
2016-09-15

Phage therapy of pseudomonas infections

#22
20160143965
2016-05-26

Bacteriophage therapy